Skip to main content
. 2020 Oct 19;10:17658. doi: 10.1038/s41598-020-74834-y

Table 2.

Percentage of resistant Staphylococcus strains to indicator antibiotics from inpatient and outpatient departments (2008–2017).

2008–2012 2013–2017
Outpatients (%) Inpatients (%) Statisticsa Outpatients (%) Inpatients (%) Statisticsa
Penicillin 94.8 96.6 n.s 95.2 96.9 n.s
Ampicillinb 10.8 12.2 n.s 12.4 13.7 n.s
Cefoxitinc 0.6 1.9 n.s 9.8 11.6 n.s
Amikacin 1.5 23.2 p < 0.001 1.1 14.2 p < 0.001
Gentamicin 4.6 23.2 p = 0.028 2.1 24.8 p < 0.001
Azithromycin 19.5 25.8 p = 0.049 32.3 33.2 n.s
Clindamycin 17.9 21.9 n.s 22.1 26.3 n.s
Ciprofloxacin 9.7 35.7 p < 0.001 12.1 25.6 p = 0.042
Doxycycline 13.3 29.8 p = 0.04 4.2 30.8 p < 0.001
Nitrofurantoin 2.6 3.3 n.s 0.5 3.8 p = 0.046
SMX/TMPd 5.6 23.2 p < 0.001 1.1 27.1 p < 0.001
Rifampicin 1.0 2.3 n.s 3.3 4.8 n.s
Vancomycine 0.0 0.0 n.s 0.0 0.0 n.s
QP/DPf 0.0 0.0 n.s 0.0 0.0 n.s
Tigecycline 0.0 0.0 n.s 0.0 0.0 n.s
Linezolid 0.0 0.0 n.s 0.0 0.0 n.s
Fusidic acid 0.0 0.0 n.s 0.0 0.0 n.s

aComparison of resistance levels among isolates originating from outpatients and inpatients.

bCalculated for S. saprophyticus isolates only.

cRepresent the ratio of MRSA isolates in S. aureus.

dSulfamethoxazole-trimethoprim.

eRepresents the ratio of VISA/VRSA strains.

fQuinpristin/dalfopristin.

n.s.: not significant (p > 0.05).